bioequivalence of vit D3 cholecalciferol [Regulatives / Guidelines]

posted by khaoula – Algeria, 2020-08-18 12:41 (155 d 20:55 ago) – Posting: # 21887
Views: 671

Dear all,
I have a question about a new formulation of vit D cholecalciferol capsule 50 000 UI : is it necessary to conduct a bioequivalence study to compare this new formulation with the reference drug vitamin D3 50 000 IU oral solution in ampoule ?
knowing that the producer of this generic formulation said that the clinical and non clinical studies can be waived for medicinal product with well established medicinal use according to articlr 10A in the DIRECTIVE 2001/ 83/EC of THE EUROPEAN PARLIAMENT
we don't have guideline in Algeria , but we follow FDA and EMA guideline, or I didnt find an answer to this question
thank you

Complete thread:

Activity
 Admin contact
21,308 posts in 4,444 threads, 1,488 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Thursday 08:36 CET (Europe/Vienna)

Politicians use statistics like drunkards use lampposts:
not for illumination, but for support.    attributed to Hans Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5